Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since meno- pause [published correction appears in JAMA. 2008;299:1426]. JAMA. 2007;297:1465 1477. 270. Grodstein F, Manson JE, Stampfer MJ, Rexrode K. Postmenopausal hor- mone therapy and stroke: role of time since menopause and age at initia- tion of hormone therapy. Arch Intern Med. 2008;168:861 866. 271. Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N. KEEPS: the Kronos Early Estrogen Prevention Study. Climacteric. 2005;8:3 12. 272. Renoux C, Dell aniello S, Garbe E, Suissa S. Transdermal and oral hor- mone replacement therapy and the risk of stroke: a nested case-control study. BMJ. 2010;340:c2519. 273. Nelson HD, Walker M, Zakher B, Mitchell J. Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. Preventive Services Task Force recommenda- tions. Ann Intern Med. 2012;157:104 113. 274. Henderson VW, Lobo RA. Hormone therapy and the risk of stroke: per- spectives 10 years after the Women s Health Initiative trials. Climacteric. 2012;15:229 234. 275. Marjoribanks J, Farquhar C, Roberts H, Lethaby A. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2012;7:CD004143. 276. Nastri CO, Lara LA, Ferriani RA, Rosa ESAC, Figueiredo JB, Martins WP. Hormone therapy for sexual function in perimenopausal and post- menopausal women. Cochrane Database Syst Rev. 2013;6:CD009672. 277. Merikangas KR. Contributions of epidemiology to our understanding of migraine. Headache. 2013;53:230 246. 278. Wolff s Headache and Other Head Pain. 7th ed. Silberstein SD, Lipton RB, Dalessio DJ, eds. New York, NY: Oxford University Press; 2001. 279. 